Phosphokinase and the usage thereof
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
N/A
app pub date -
Jun 28, 2006
filing date -
Dec 31, 2003
priority date (Note) -
Abandoned
status (Latency Note)
Importance
Abstract
The present invention relates to a novel phosphokinase, RX50 protein, polynucleotide encoding RX50 protein and the recombinant method of producing the same. RX50 protein can interact with p21 and cyclin D3, and inhibit the transcription of p53. Therefore, it can be used as a drug target for new drug selection.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully